Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05946603 · ClinicalTrials.gov registry record · Phase 2
IS-002 Phase 2 Prostate Cancer Study
A Phase 2 study, sponsored by Intuitive Surgical.
- Completed
- Registry status
- Phase 2
- Development phase
- 59
- Enrollment target
NCT05946603 is a Phase 2 study that has completed, run by Intuitive Surgical. The registered enrollment target is 59 participants.
The verdict
NCT05946603, a Phase 2 study, has completed, sponsored by Intuitive Surgical.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 59 participants
- Enrollment target
Study Summary
Phase 2 randomized controlled multi-center study of IS-002, in conjunction with near-infrared (NIR) fluorescence imaging, for identification of prostate cancer during robotic-assisted radical prostatectomy (RARP) with (extended) pelvic lymph node dissection ((e)PLND) using the da Vinci® X/Xi Surgical System with Firefly® Fluorescence Imaging.
Interventions
- DRUG Administration of IS-002
- DEVICE Firefly fluorescent imaging
- PROCEDURE robotic-assisted laparoscopic prostatectomy with pelvic lymph node dissection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2023-06-16 |
| Est. Completion | 2025-05-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05946603
The ClinicalTrials.gov registry entry for NCT05946603 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intuitive Surgical, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Administration of IS-002 is the first listed.
NCT05946603 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05946603 about?
NCT05946603 is a clinical study titled "IS-002 Phase 2 Prostate Cancer Study". Phase 2 randomized controlled multi-center study of IS-002, in conjunction with near-infrared (NIR) fluorescence imaging, for identification of prostate cancer during robotic-assisted radical prostatectomy (RARP) with (extended) pelvic lymph node dissection ((e)PLND) using the da Vinci® X/Xi Surgica...
What is the current status of trial NCT05946603?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 59 participants. The study started on 2023-06-16. Estimated completion is 2025-05-23.
What interventions are being tested in trial NCT05946603?
The interventions under investigation include: Administration of IS-002 (DRUG), Firefly fluorescent imaging (DEVICE), robotic-assisted laparoscopic prostatectomy with pelvic lymph node dissection (PROCEDURE).
Who is sponsoring clinical trial NCT05946603?
This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.